Keratoconjunctivitis sicca therapy

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 3314

Patent

active

043715222

ABSTRACT:
Discomfort in patients suffering from keratoconjunctivitis sicca is considerably relieved by instilling into the eyes of the afflicted patient a small amount of hypotonic solution suitably of a strength of between 25 and 75 percent isotonicity.

REFERENCES:
patent: 2547653 (1951-04-01), Minnis et al.
patent: 4039662 (1977-08-01), Hecht et al.
Chem. Abst. 63, 16,126(e-f), (1965), Grosz et al.
Contact Lenses Practice, 2nd Ed., Mandell, p. 513, (1977).
Int. Ophthal. Clin. 13, 145-153, (1973), Lemp, "Tear Substitute in the Treatment of Dry Eye".
Int. Ophthal. Clin. 13, 221-229, (1973), Lemp, "Artificial Tear Solution".
Handbook of Non-Prescription Drugs, 5th Ed., pp. 228-232 & 234-235, (1977).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Keratoconjunctivitis sicca therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Keratoconjunctivitis sicca therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Keratoconjunctivitis sicca therapy will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2407358

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.